Introduction:
Piramal Pharma Solutions plans to invest USD 40 million in new equipment and next generation technologies.
Features:
This investments include areas such as Anti-body Drug Conjugation (ADC), Advanced Flow Reactor (ARF) and Biocatalysis Centre of Excellence systems.
In addition to the investment of USD 40 million in new equipment and technologies, they are also augmenting related infrastructure. Recently the company completed a green field facility ($10M) to double its Discovery Services capacity, and also approved a $20M capacity expansion for Hormonal (Morpeth) and ADC (Grangemouth) manufacturing.
Specifications:
| Company Name | Piramal Pharma Solutions |
| Type | New Equipment & Technologies |
| Estimated Cost | $40 million |
| Location | India |
